Hamilton Point Investment Advisors, LLC Amgen Inc Transaction History

Hamilton Point Investment Advisors, LLC

$555 Million
Q3 2024

A detailed history of Hamilton Point Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Hamilton Point Investment Advisors, LLC holds 34,682 shares of AMGN stock, worth $9.71 Million. This represents 2.01% of its overall portfolio holdings.

Number of Shares

34,682

Previous 34,323 1.05%

Holding current value

$9.71 Million

Previous $10.7 Million 4.2%

% of portfolio

2.01%

Previous 2.07%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $111,067 - $121,119	359 Added 1.05%	34,682 $11.2 Million
Q2 2024 Aug 06, 2024	BUY	$262.75 - $319.31 $86,182 - $104,733	328 Added 0.96%	34,323 $10.7 Million
Q1 2024 May 07, 2024	SELL	$268.87 - $324.56 $335,818 - $405,375	-1,249 Reduced 3.54%	33,995 $9.67 Million
Q4 2023 Jan 30, 2024	BUY	$255.7 - $288.46 $134,498 - $151,729	526 Added 1.52%	35,244 $10.2 Million
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $65,813 - $81,709	-301 Reduced 0.86%	34,718 $9.33 Million
Q2 2023 Aug 03, 2023	SELL	$214.27 - $253.37 $84,422 - $99,827	-394 Reduced 1.11%	35,019 $7.77 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $309,558 - $377,299	1,371 Added 4.03%	35,413 $8.56 Million
Q4 2022 Jan 30, 2023	BUY	$229.03 - $291.01 $31,148 - $39,577	136 Added 0.4%	34,042 $8.94 Million
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $164,304 - $185,305	732 Added 2.21%	33,906 $7.64 Million
Q2 2022 Jul 26, 2022	BUY	$230.71 - $256.74 $171,878 - $191,271	745 Added 2.3%	33,174 $8.07 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $196,027 - $216,857	894 Added 2.83%	32,429 $7.84 Million
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $179,389 - $205,295	902 Added 2.94%	31,535 $7.09 Million
Q3 2021 Oct 26, 2021	BUY	$212.27 - $248.7 $66,440 - $77,843	313 Added 1.03%	30,633 $6.51 Million
Q2 2021 Aug 02, 2021	BUY	$233.58 - $259.14 $68,438 - $75,928	293 Added 0.98%	30,320 $7.39 Million
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $126,932 - $147,919	572 Added 1.94%	30,027 $7.47 Million
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $6,058 - $7,214	28 Added 0.1%	29,455 $6.77 Million
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $202,737 - $225,460	864 Added 3.02%	29,427 $7.48 Million
Q2 2020 Aug 03, 2020	BUY	$197.81 - $242.74 $108,597 - $133,264	549 Added 1.96%	28,563 $6.74 Million
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $241,103 - $319,769	1,323 Added 4.96%	28,014 $5.68 Million
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $3,594 - $4,620	-19 Reduced 0.07%	26,691 $6.43 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $109,863 - $131,639	631 Added 2.42%	26,710 $5.17 Million
Q2 2019 Jul 18, 2019	BUY	$166.7 - $195.41 $41,174 - $48,266	247 Added 0.96%	26,079 $4.81 Million
Q1 2019 May 03, 2019	BUY	$180.87 - $203.88 $64,570 - $72,785	357 Added 1.4%	25,832 $4.91 Million
Q4 2018 Feb 04, 2019	BUY	$178.4 - $208.25 $235,309 - $274,681	1,319 Added 5.46%	25,475 $4.96 Million
Q3 2018 Oct 29, 2018	BUY	$185.29 - $208.89 $13,711 - $15,457	74 Added 0.31%	24,156 $5.01 Million
Q2 2018 Jul 18, 2018	BUY	$166.05 - $186.51 $91,161 - $102,393	549 Added 2.33%	24,082 $4.45 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $4,744 - $5,544	28 Added 0.12%	23,533 $4.01 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $146,847 - $164,073	870 Added 3.84%	23,505 $4.09 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $18,401 - $21,010	110 Added 0.49%	22,635 $4.22 Million
Q2 2017 Aug 14, 2017	BUY	N/A	22,525	22,525 $3.88 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Point Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Point Investment Advisors, LLC with notifications on news.

Account

Hamilton Point Investment Advisors, LLC Amgen Inc Transaction History